Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema

Acta Ophthalmologica

Volumn 88, Issue 5, 2010, Pages 558-563

  Karacorlu, Murat ^a   Ozdemir, Hakan ^a   Senturk, Fevzi ^a   Karacorlu, Serra Arf ^a   Uysal, Omer ^b  

^a Istanbul Retina Institute Inc   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

diabetic macular oedema; fixation location; fixation stability; intravitreal triamcinolone acetonide; macular function; microperimetry; MP 1

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; VISUAL ACUITY;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; PERIMETRY; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 77954630774     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01497.x     Document Type: Article

References (13)

1. Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, Gaudic A Massin P (2006 Intravitreal triamcinolone for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial. Acta Ophthalmol Scand 84 : 624 630. (Pubitemid 44317541)
2. Brown MM, Brown GC, Sharma S Shah G (1999 Utility values and diabetic retinopathy. Am J Ophthalmol 129 : 324 330.
3. Jonas JB Söfker A (2001 Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular oedema. Am J Ophthalmol 132 : 425 427. (Pubitemid 32768624)
4. Karacorlu M, Ozdemir H, Karacorlu S, Alacali N, Mudun B Burumcek E (2005 Intravitreal triamcinolone acetonide as a primary therapy in diabetic macular oedema. Eye 19 : 382 386.
5. Klein R, Klein BE, Moss SE, Davis MD Demets DL (1984 The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular oedema. Ophthalmology 91 : 1464 1474.
6. Lamoureux EL, Hassell JB Keeffe JE (2004 The impact of diabetic retinopathy on participation in daily living. Arch Ophthalmol 122 : 84 88.
7. Margolis R, Singh RP, Bhatnagar P Kaiser PK (2008 Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema. Acta Ophthalmol 86 : 105 110.
8. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E Baumal C (2002 Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 109 : 920 927.
9. Midena E, Rabin PP, Pilotto E, Ghirlando A, Convento E Varano M (2004 Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol 19 : 55 61. (Pubitemid 39658410)
10. Okada K, Yamamoto S, Mizunoya S, Hoshino A, Arai M Takatsuna Y (2006 Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular oedema. Eye 20 : 805 809.
11. Rohrschneider K, Springer C, Blültmann S Völcker HE (2005 Microperimetry - comparison between the micro perimeter 1 and scanning laser ophthalmoscope - fundus perimetry. Am J Ophthalmol 139 : 125 134. (Pubitemid 40094849)
12. Sivaprasad S, McCluskey P Lightman S (2006 Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand 84 : 722 733.
13. Vinten M, Larsen M, Lund-Andersen H, Sander B La Cour M (2007 Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema. Acta Ophthalmol Scand 85 : 21 26.